BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31275245)

  • 1. Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review.
    Papadakis G; Kandaraki EA; Tseniklidi E; Papalou O; Diamanti-Kandarakis E
    Front Endocrinol (Lausanne); 2019; 10():388. PubMed ID: 31275245
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome.
    Trakakis E; Rizos D; Loghis C; Chryssikopoulos A; Spyropoulou M; Salamalekis E; Simeonides G; Vagopoulos V; Salamalekis G; Kassanos D
    Endocr J; 2008 Mar; 55(1):33-9. PubMed ID: 18187875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome.
    Pignatelli D
    Front Horm Res; 2013; 40():158-70. PubMed ID: 24002412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
    Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
    Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M; Azziz R; Beires J; Pignatelli D
    Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffuse hypertrichosis revealing non-classical congenital adrenal hyperplasia].
    Berthin C; Sibilia P; Martins-Hericher J; Donzeau A; Martin L
    Ann Dermatol Venereol; 2018 Apr; 145(4):270-277. PubMed ID: 29525066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome.
    Kępczyńska-Nyk A; Kuryłowicz A; Nowak A; Bednarczuk T; Ambroziak U
    J Endocrinol Invest; 2021 Mar; 44(3):505-513. PubMed ID: 32557272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
    Moran C; Azziz R
    Semin Reprod Med; 2003 Aug; 21(3):295-300. PubMed ID: 14593552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of non classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with acne: a hospital-based cross-sectional study.
    Trakakis E; Papadavid E; Dalamaga M; Koumaki D; Stavrianeas N; Rigopoulos D; Creatsas G; Kassanos D
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1448-51. PubMed ID: 22703023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
    Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
    J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of clinical features and etiological diagnostic indices of reproductive age women with hyperandrogenism].
    Zhang TT; Yang XL; Yang SX; Shang J; Xue Q; Zhang X; Zhu YL; Huang YY; Zhang DH; Sun YL; Lang C; Gao XZ; Cai HB; Zhang JQ; Xu Y; Gao Y
    Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):412-417. PubMed ID: 35144340
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia.
    Saygili F; Oge A; Yilmaz C
    Horm Res; 2005; 63(6):270-4. PubMed ID: 15956788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia.
    Krysiak R; Drosdzol-Cop A; Skrzypulec-Plinta V; Okopien B
    J Sex Med; 2016 Jan; 13(1):34-9. PubMed ID: 26755084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Polycystic Ovary Syndrome from Adrenal Disorders.
    Yesiladali M; Yazici MGK; Attar E; Kelestimur F
    Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E; Kunicki M; Radowicki S
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing.
    Avivi I; Pollack S; Gideoni O; Linn S; Blumenfeld Z
    Fertil Steril; 1996 Oct; 66(4):557-63. PubMed ID: 8816616
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.